Our CLIA licensed and College of American Pathologists (CAP) accredited clinical sequencing offers physicians, clinical diagnostic labs, and clinical researchers access to high quality sequencing services managed under CLIA regulations.
The Broad has analyzed more than 300,000 clinical samples and 38 million COVID tests, delivering trusted results with rapid turnaround for clinical use and in support of clinical trials.
Explore the development, clinical validation, and implementation of a novel mass-spectrometry based CLIA assay that reliably detects a single-base insertion mutation within a 60bp repeat unit In the MUC1 gene.
Learn about the validation of our end-to-end Illumina PCR-free WGS pipeline, including laboratory, analytical, and computational analyses.
Learn about the validation of Firehose tools, MuTect and Indelocator, for somatic variant calling applied to clinical WES data from matched tumor and normal patient samples.
Learn more about our clinically validated workflows.